Nugen Medical Devices Inc (NGMD.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 313 | 158 | 160 | 160 | 182 |
| Income taxes - deferred | 3 | 0 | 0 | 0 | 6 |
| Accounts receivable | -63 | -101 | 87 | -81 | 69 |
| Accounts payable and accrued liabilities | -1,605 | 705 | 672 | 195 | 208 |
| Other Working Capital | -1,483 | 615 | 527 | 114 | 470 |
| Other Operating Activity | 173 | -1,880 | -1,842 | -920 | -1,475 |
| Operating Cash Flow | $-2,663 | $-504 | $-397 | $-532 | $-539 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | N/A | N/A | 0 |
| Net Acquisitions | 5 | N/A | N/A | N/A | 0 |
| Investing Cash Flow | $2 | $N/A | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | N/A | N/A | N/A | 95 |
| Debt Issued | 25 | N/A | N/A | N/A | 245 |
| Common Stock Issued | 4,244 | 475 | 93 | 697 | 0 |
| Other Financing Activity | -50 | 100 | 0 | 0 | 243 |
| Financing Cash Flow | $4,219 | $575 | $93 | $697 | $583 |
| Exchange Rate Effect | -3 | -1 | -2 | -11 | -3 |
| Beginning Cash Position | 195 | 125 | 430 | 276 | 235 |
| End Cash Position | 1,750 | 195 | 125 | 430 | 276 |
| Net Cash Flow | $1,558 | $71 | $-303 | $164 | $44 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,663 | -504 | -397 | -532 | -539 |
| Free Cash Flow | -2,663 | -504 | -397 | -532 | -539 |